A randomised placebo-controlled multicentre trial of intravenous semapimod HCl for moderate to severe Crohn's disease

Iris Dotan*, Daniel Rachmilewitz, Stefan Schreiber, Rami Eliakim, C. Janneke Van Der Woude, Asher Kornbluth, Alan L. Buchman, Shimon Bar-Meir, Bernd Bokemeyer, Eran Goldin, Christian Maaser, Uma Mahadevan, Ursula Seidler, Jörg C. Hoffman, Douglas Homoky, Terry Plasse, Barbara Powers, Paul Rutgeerts, Daniel Hommes

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

51 Scopus citations

Fingerprint

Dive into the research topics of 'A randomised placebo-controlled multicentre trial of intravenous semapimod HCl for moderate to severe Crohn's disease'. Together they form a unique fingerprint.

Medicine & Life Sciences